Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
K-Fast Holding B | KFASTB | Mar 18, 2024 | 17.66 | +0.34 |
K2A Knaust & Andersson Fastigheter B | K2AB | Mar 18, 2024 | 7.50 | -4.58 |
K2A Knaust & Andersson Fastigheter Pref | K2APREF | Mar 18, 2024 | 197.50 | -0.25 |
KABE Group B | KABEB | Mar 18, 2024 | 301.00 | -2.90 |
Kakel Max | KAKEL | Mar 18, 2024 | 9.80 | 0.00 |
Kallebäck Property Invest | KAPIAB | Mar 18, 2024 | 187.00 | 0.00 |
Kambi Group | KAMBI | Mar 18, 2024 | 99.75 | +0.15 |
Kancera | KAN | Mar 18, 2024 | 1.87 | -2.81 |
Karnov Group | KAR | Mar 18, 2024 | 65.40 | -1.65 |
Karolinska Development B | KDEV | Mar 18, 2024 | 1.52 | -2.81 |
Katalysen Ventures AB | KAV | Mar 18, 2024 | 18.30 | +19.61 |
KebNi B | KEBNIB | Mar 18, 2024 | 1.40 | -1.55 |
Kentima Holding B | KENH | Mar 18, 2024 | 1.78 | -4.30 |
Kiliaro | KILI | Mar 18, 2024 | 0.98 | -8.04 |
Kindred Group SDB | KINDSDB | Mar 18, 2024 | 122.95 | 0.00 |
Kinnevik A | KINVA | Mar 18, 2024 | 107.60 | -4.27 |
Kinnevik B | KINVB | Mar 18, 2024 | 107.20 | -5.30 |
Kjell Group | KJELL | Mar 18, 2024 | 19.30 | -2.03 |
KlaraBo | KLARAB | Mar 18, 2024 | 19.12 | -1.34 |
Klaria Pharma Holding | KLAR | Mar 18, 2024 | 0.29 | -9.06 |
Klimator | KLIMAT | Mar 18, 2024 | 1.45 | -1.37 |
Knowit | KNOW | Mar 18, 2024 | 157.80 | -4.36 |
Kollect on Demand Holding | KOLL | Mar 18, 2024 | 1.40 | +2.95 |
Kontigo Care | KONT | Mar 18, 2024 | 2.26 | +5.12 |
Kopparbergs B | KOBRB | Mar 18, 2024 | 111.50 | -0.89 |
Kopy Goldfields | KOPY | Mar 18, 2024 | 0.38 | -1.57 |
Krona Public Real Estate | KRONA | Mar 18, 2024 | 39.80 | -11.56 |
Kvix | KVIX | Mar 18, 2024 | 0.37 | +8.88 |
Lagercrantz Group B | LAGRB | Mar 18, 2024 | 154.90 | +1.24 |
Lammhults Design Group B | LAMMB | Mar 18, 2024 | 27.60 | +2.22 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.